Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients

References

• Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.
   PubMed Web of Science ®Google Scholar
• Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
   PubMed Web of Science ®Google Scholar
• Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64(2):278–289.
   PubMed Web of Science ®Google Scholar
• Kumar VA, Sidell MA, Yang WT, et al. Predictors of peritonitis, hospital days, and technique survival for peritoneal dialysis patients in a managed care setting. Perit Dial Int. 2014;34(2):171–178.
   PubMed Web of Science ®Google Scholar
• Piraino B, Bernardini J, Brown E, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011;31(6):614–630.
   PubMed Web of Science ®Google Scholar
• Aguirre Valadez JM, Rivera-Espinosa L, Mendez-Guerrero O, et al. Intestinal permeability in a patient with liver cirrhosis. Ther Clin Risk Manag. 2016;12:1729–1748.
   PubMed Web of Science ®Google Scholar
• Chang CS, Yang SS, Kao CH, et al. Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol. 2001;36(1):92–96.
   PubMed Web of Science ®Google Scholar
• Hirako M, Kamiya T, Misu N, et al. Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J Gastroenterol. 2005;40(12):1116–1122.
   PubMed Web of Science ®Google Scholar
• Strid H, Simren M, Stotzer PO, et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion. 2003;67(3):129–137.
   PubMed Web of Science ®Google Scholar
• Stompor T, Hubalewska-Hola A, Staszczak A, et al. Association between gastric emptying rate and nutritional status in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int. 2002;22(4):500–505.
   PubMed Web of Science ®Google Scholar
• Wang F, Jiang H, Shi K, et al. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton). 2012;17(8):733–738.
   PubMed Web of Science ®Google Scholar
• Shi K, Wang F, Jiang H, et al. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig Dis Sci. 2014;59(9):2109–2117.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Zhao YY, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant. 2016;31(5):737–746.
   PubMed Web of Science ®Google Scholar
• Thalheimer U, De Iorio F, Capra F, et al. Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study. Eur J Gastroenterol Hepatol. 2010;22(10):1228–1234.
   PubMed Web of Science ®Google Scholar
• Cereijido M, Shoshani L, Contreras RG. Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity. Am J Physiol Gastrointest Liver Physiol. 2000;279(3):G477–G482.
   PubMed Web of Science ®Google Scholar
• Dudek SM, Jacobson JR, Chiang ET, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem. 2004;279(23):24692–24700.
   PubMed Web of Science ®Google Scholar
• English D, Kovala AT, Welch Z, et al. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J Hematother Stem Cell Res. 1999;8(6):627–634.
   PubMedGoogle Scholar
• Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood. 2005;105(8):3178–3184.
   PubMed Web of Science ®Google Scholar
• McVerry BJ, Garcia JG. Endothelial cell barrier regulation by sphingosine 1-phosphate. J Cell Biochem. 2004;92(6):1075–1085.
   PubMed Web of Science ®Google Scholar
• Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta. 2002;1582(1–3):204–215.
   PubMed Web of Science ®Google Scholar
• Singleton PA, Dudek SM, Chiang ET, et al. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. Faseb J. 2005;19(12):1646–1656.
   PubMed Web of Science ®Google Scholar
• Singleton PA, Dudek SM, Ma SF, et al. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem. 2006;281(45):34381–34393.
   PubMed Web of Science ®Google Scholar
• Greenspon J, Li R, Xiao L, et al. Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. Dig Dis Sci. 2011;56(5):1342–1353.
   PubMed Web of Science ®Google Scholar
• van Olden RW, Krediet RT, Struijk DG, et al. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7(5):745–750.
   PubMed Web of Science ®Google Scholar
• Nolph KD, Moore HL, Prowant B, et al. Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1993;13(3):178–183.
   PubMed Web of Science ®Google Scholar
• Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33(1):27–39. The American Journal of Clinical Nutrition
   PubMed Web of Science ®Google Scholar
• Salzer WL. Peritoneal dialysis-related peritonitis: challenges and solutions. Int J Nephrol Renovasc Dis. 2018;11:173–186.
   PubMed Web of Science ®Google Scholar
• Singharetnam W, Holley JL. Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial, or fungal peritonitis. Perit Dial Int. 1996;16(4):423–425.
   PubMed Web of Science ®Google Scholar
• Wood CJ, Fleming V, Turnidge J, et al. Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis. 1992;19(3):257–263.
   PubMed Web of Science ®Google Scholar
• Su CY, Pei J, Lu XH, et al. Gastrointestinal symptoms predict peritonitis rates in CAPD patients. CN. 2012;77(04):267–274.
   Google Scholar
• Kosmadakis G, Albaret J, da Costa Correia E, et al. Gastrointestinal disorders in peritoneal dialysis patients. Am J Nephrol. 2018;48(5):319–325.
   PubMed Web of Science ®Google Scholar
• Yip T, Tse KC, Lam MF, et al. Colonic diverticulosis as a risk factor for peritonitis in Chinese peritoneal dialysis patients. Perit Dial Int. 2010;30(2):187–191.
   PubMed Web of Science ®Google Scholar
• Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34(1):32–37.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang P, Jiang H, et al. Gut bacterial translocation contributes to microinflammation in experimental uremia. Dig Dis Sci. 2012;57(11):2856–2862.
   PubMed Web of Science ®Google Scholar
• Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–670.
   PubMed Web of Science ®Google Scholar
• March DS, Graham-Brown MP, Stover CM, et al. Intestinal barrier disturbances in haemodialysis patients: mechanisms, consequences, and therapeutic options. Biomed Res Int. 2017;2017:5765417.
   PubMed Web of Science ®Google Scholar
• Lau WL, Kalantar-Zadeh K, Vaziri ND. The gut as a source of inflammation in chronic kidney disease. Nephron. 2015;130(2):92–98.
   PubMed Web of Science ®Google Scholar
• Greenspon J, Li R, Xiao L, et al. Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway. Dig Dis Sci. 2009;54(3):499–510.
   PubMed Web of Science ®Google Scholar
• Calise S, Blescia S, Cencetti F, et al. Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors. Biochim Biophys Acta. 2012;1823(2):439–450.
   PubMed Web of Science ®Google Scholar
• Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol. 2011;11(6):403–415.
   PubMed Web of Science ®Google Scholar
• Nagahashi M, Hait NC, Maceyka M, et al. Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. Adv Biol Regul. 2014;54:112–120.
   PubMedGoogle Scholar
• Kleinwort A, Luhrs F, Heidecke CD, et al. S1P signalling differentially affects migration of peritoneal B cell populations in vitro and influences the production of intestinal IgA In Vivo. IJMS. 2018;19(2):391.
   Google Scholar
• Winkler MS, Nierhaus A, Holzmann M, et al. Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Crit Care. 2015;19(1):372.
   PubMedGoogle Scholar
• Li PK, Ng JK, McIntyre CW. Inflammation and peritoneal dialysis. Semin Nephrol. 2017;37(1):54–65.
   PubMed Web of Science ®Google Scholar
• Huang JW, Lien YC, Wu HY, et al. Lean body mass predicts long-term survival in Chinese patients on peritoneal dialysis. PloS One. 2013;8(1):e54976.
   PubMed Web of Science ®Google Scholar
• Kerschbaum J, Konig P, Rudnicki M. Risk factors associated with peritoneal-dialysis-related peritonitis. Int J Nephrol. 2012;2012:483250.
   PubMedGoogle Scholar
• Vargas E, Apewokin S, Madan R. Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection. Anaerobe. 2017;45:101–105.
   PubMed Web of Science ®Google Scholar
• Lang CL, Wang MH, Hung KY, et al. Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon? Epma J. 2013;4(1):17.
   PubMedGoogle Scholar
• Fuentes E, Fuentes M, Alarcon M, et al. Immune system dysfunction in the elderly. An Acad Bras Cienc. 2017;89(1):285–299.
   PubMed Web of Science ®Google Scholar